Biomega
Biomega is a Norwegian biorefinery that converts Atlantic salmon rest raw materials into premium functional ingredients — proteins, peptides, oils, and minerals — for human nutrition, pet food, and aquafeed manufacturers worldwide, using patented continuous enzymatic hydrolysis technology.
- Company typePrivate
- Founded2001
- HeadquartersBergen, Norway
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Biomega does
Biomega is a Norwegian biorefinery company that converts Atlantic salmon rest raw materials into premium functional ingredients for three end markets: human nutrition (SalMe brand: salmon oil, peptides, collagen peptides), premium pet food (Salmigo brand: protein concentrates, salmon oil, and glycerine-replacement products), and aquaculture feed. Founded in Bergen, Norway in 2000, the company operates two production facilities — the original 55,000-tonne Skaganeset biorefinery near Bergen built in 2002, and a next-generation biorefinery at Hirtshals, Denmark completed in December 2022 and purpose-built for the human nutrition market.
The company's core technology is a patented continuous enzymatic hydrolysis process developed over 20+ years, which enables 24/7, 365-day operation with consistent quality through a 'first-in, first-out' processing methodology. The technology is complemented by patented tailor-made reactors and fraction separation systems that isolate pure soluble proteins, non-soluble proteins, oils, and minerals. Biomega holds a comprehensive set of regulatory certifications including FSSC22000, GMP+, MarinTrust, Kosher, Halal, HACCP, ISO 9001, and U.S. FDA compliance across both facilities.
Biomega operates as a B2B ingredient supplier, selling directly to enterprise manufacturers in the health and nutrition, pet food, and aquaculture industries across EMEA, Americas, and Asia. Pricing is quote-based and not publicly disclosed. The company employs approximately 60 people across Norway and Denmark as of January 2026, when it was acquired by Norwegian industrial group GC Rieber AS, returning it to Norwegian ownership after a period under US-based AMERRA Capital Management.
Biomega firmographics
Firmographics- Name
- Biomega
- Legal name
- Biomega Group AS
- Website
- https://biomegagroup.com/
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Biomega is a Norwegian biorefinery that converts Atlantic salmon rest raw materials into premium functional ingredients — proteins, peptides, oils, and minerals — for human nutrition, pet food, and aquafeed manufacturers worldwide, using patented continuous enzymatic hydrolysis technology.
- Ownership category
- akta.pro rank
Biomega industry classification
Industry- Product category
- Marine Functional Ingredients
- NAICS
- Seafood Product Preparation and Packaging (3117), Animal Food Manufacturing (3111), Aquaculture (1125)
- SIC
- Prepared Fresh Or Frozen Fish & Seafoods (2092), Fats & Oils (2070), Food And Kindred Products (2000)
- akta.pro primary industry
- Seafood By-Products & Fishmeal/Fish Oil Processing (Rendering, Hydrolysates, Collagen) (AFANADAJ)
- akta.pro secondary industries
- Bio-based Food & Flavor Ingredients (Non-fuel Co-products: sweeteners, organic acids, flavors) (EUAAAIAJ), Bio-based Animal Feed Ingredients & Nutrition Co-products (e.g., DDGS, protein meals, yeast) (EUAAAIAI)
Keywords
Where Biomega is headquartered
LocationHeadquarters
- HQ city
- Bergen
- HQ country
- Norway
- HQ region
- Europe
Offices3 records
Markets served
Biomega business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure
Revenue model
- B2B Ingredient Sales: Sale of premium Atlantic salmon-based functional ingredients to manufacturers in human nutrition, pet food, and aquaculture markets. Revenue generated through product sales to B2B customers globally.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Biomega product offering
Product offeringCore offering
Biomega is a biorefinery company that processes Atlantic salmon rest raw materials into premium functional ingredients (proteins, peptides, oils, and minerals) using a patented continuous enzymatic hydrolysis technology. It sells these ingredients under the SalMe® brand (Salmon Oil, Peptides, Collagen Peptides) to human nutrition brands, the Salmigo® brand (Active, Salmon Oil, Protect L60) to premium pet food manufacturers, and salmon oil to aquaculture feed producers, serving customers in Europe, the USA, and Asia.
Product overview
Biomega is a biorefinery company producing Atlantic salmon-based functional ingredients for three market segments: human nutrition (SalMe brand: SalMe Salmon Oil, SalMe Peptides, SalMe Collagen Peptides), premium pet food (Salmigo brand: Salmigo Active, Salmigo Salmon Oil, Salmigo Protect L60), and aquaculture feed (Salmon Oil). All products are manufactured using the company's proprietary continuous enzymatic hydrolysis technology that processes salmon rest raw materials into premium peptides, proteins, and oils.
Differentiator
Problem solved
Functional benefit
Brands
- SalMe®: Product line for human nutrition including SalMe Salmon Oil, SalMe Peptides, and SalMe Collagen Peptides - sustainably sourced Atlantic salmon-based ingredients for health and nutrition market
- Salmigo®
Products and services
- SalMe Salmon Oil Food-grade Atlantic salmon oil naturally processed to provide omega-3 fatty acids (EPA and DHA) and rich in natural astaxanthin antioxidant, available in liquid format for capsules and functional food applications in the human nutrition market.
- SalMe Peptides 100% water-soluble salmon peptides produced via continuous enzymatic hydrolysis, rich in micronutrients including Vitamin B12, Vitamin B6, and taurine, suitable for functional food applications such as soups, juices, and gummies.
- SalMe Collagen Peptides Natural source of type I collagen peptides that are 100% water soluble with a balanced micronutrient composition, designed for the human health and nutrition market including beauty-from-within and joint health applications.
- Salmigo Active Protein concentrate powder containing approximately 70% protein with high peptide content and valuable micronutrients including taurine and B vitamins, offering highly digestible protein with faster absorption than intact native proteins, designed for premium pet food and snack applications.
- Salmigo Salmon Oil Natural source of omega-3 fatty acids (EPA and DHA) with high natural astaxanthin content and approximately 44% omega-9 fatty acids with a balanced omega-6 to omega-3 ratio of around 1:1, designed as a clean-label ingredient for pet skin, coat, bone, and joint supplements.
- Salmigo Protect L60 Liquid salmon protein concentrate containing more than 50% protein with free amino acids and valuable micronutrients, offering high biological value and acting as a glycerine replacement in semi-moist petfood with excellent palatability for cats and dogs in premium pet food, snacks, and treats.
- Salmon Oil (Aquafeed) Highly functional and versatile aquaculture feed ingredient naturally processed from sustainably sourced Atlantic salmon raw materials, containing natural omega-3 fatty acids with balanced fatty acid composition and fat-soluble vitamins, produced via continuous enzymatic hydrolysis for gentle nutrient preservation.
Quantifiable outcome
- Essential amino acids from SalMe Peptides were rapidly digested and absorbed into circulation, comparable to milk protein efficiency for muscle tissue remodelling
- +1 more outcomes
Companies that use Biomega
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Biomega technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Biomega partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- University of BirminghamcoreBiomega commissioned a comprehensive study with University of Birmingham researchers to investigate the potential of SalMe Peptides and how amino acids from salmon peptides are metabolised and absorbed. Results showed essential amino acids were rapidly digested and absorbed similar to milk protein efficiency.
- KitchenTown BerlincorePartnership with KitchenTown Berlin food innovation company to develop fresh application concepts for SalMe Peptides, SalMe Collagen Peptides, and SalMe Salmon Oil. Developed functional soups, ready-to-mix drinks, and sustainable snacks for health and nutrition brands.
- Passion4FoodcoreCollaboration with Passion4Food dedicated to pioneering innovative ingredients and pushing boundaries of traditional petfood formulations. Conducted study showing Salmigo Protect L60 can replace glycerine as a nutritional and value-adding alternative in petfood formulations.
- NofimaminorResearch partnership as part of biomega's open innovation network for ongoing innovation in uncovering novel nutritional benefits of products.
- University of BergenminorResearch partnership as part of biomega's open innovation network for ongoing innovation in uncovering novel nutritional benefits of products and enhancing biorefining techniques.
- University of IllinoisminorResearch partnership as part of biomega's open innovation network for ongoing innovation in uncovering novel nutritional benefits of products.
Scale indicators6 records
Recent moves8 records
Expansion highlights6 records
Biomega competitors and assessment
Company assessmentDirect peers
- Scanbio Marine Ingredients: Norwegian marine biorefining company producing protein concentrates, fishmeal, and fish oil from whitefish by-products. Directly comparable to Biomega in geography (Norway), upstream raw material (marine rest raw materials), and downstream B2B ingredient products for aquafeed and pet food.
- Havsbrún: Faroese fishmeal and fish oil producer owned by Bakkafrost. Comparable to Biomega in salmon/aquaculture-derived marine ingredients, serving aquafeed markets with sustainability certifications similar to MarinTrust.
- TripleNine Group: Danish fishmeal and fish oil producer operating one of the largest marine biorefineries in Europe. Closely comparable to Biomega in core activity (processing marine raw materials into proteins and oils) and regional footprint (Nordic/Danish production serving B2B feed and nutrition markets).
- Symrise Diana Pet Food: Symrise's Diana Pet Food division produces palatants and functional ingredients for premium pet food from marine and animal proteins. Direct competitor to Biomega's Salmigo pet food ingredient line and increasingly relevant in the premium pet food B2B ingredient space.
- FF Skagen: Danish fishmeal and fish oil manufacturer based in Skagen, Denmark, processing primarily sand eel, blue whiting, and other industrial fish species into marine proteins and oils. Direct competitor in Nordic marine ingredient production serving aquafeed and pet food B2B customers.
Others
- VivoMega (GC Rieber VivoMega): Sister company under GC Rieber Gruppen producing high-concentration omega-3 from fish oil. Not a competitor but a related portfolio asset enabling vertical synergies (fish oil source/destination) for Biomega under shared ownership.
- BioMar Group: Global aquafeed manufacturer and likely Biomega customer for salmon oil and protein ingredients. Comparable in adjacent value-chain position and salmon aquaculture focus, representing both a downstream customer opportunity and an upstream vertical integration reference point.
Broad incumbents
- Darling Ingredients: US-headquartered global rendering and specialty ingredients company (including Diamond Pet Food ingredients and Rousselot collagen). Much larger and more diversified than Biomega, but operates in adjacent rendering/biorefining of animal by-products into proteins, oils, and collagen for feed, pet food, and nutrition markets.
- Cargill Animal Nutrition: Global agricultural commodity and animal nutrition giant with aquafeed, pet food, and specialty ingredient businesses. Serves as a B2B incumbent in salmon-derived proteins and oils, potentially both a competitor and customer/supplier in certain ingredient categories.
- SARIA Group: European leader in rendering and animal by-product valorization (including SARIA Bio-Industries for proteins, fats, and pet food ingredients). Broader scope than Biomega across multiple animal species and geographies, but directly comparable in the rendering-to-ingredients operating model.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Biomega compliance and trust
Trust signalCompliance8 records
Biomega financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biomega leadership team
Management profileNumber of profiles
Profiles8 records
Biomega subsidiaries and ownership
Company hierarchySubsidiaries2 records
Biomega funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biomega M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biomega
What does Biomega do?
Biomega is a biorefinery company that processes Atlantic salmon rest raw materials into premium functional ingredients (proteins, peptides, oils, and minerals) using a patented continuous enzymatic hydrolysis technology. It sells these ingredients under the SalMe® brand (Salmon Oil, Peptides, Collagen Peptides) to human nutrition brands, the Salmigo® brand (Active, Salmon Oil, Protect L60) to premium pet food manufacturers, and salmon oil to aquaculture feed producers, serving customers in Europe, the USA, and Asia.
Is Biomega a public or private company?
Biomega is a private company. It is classified as corporate owned and is currently operating.
When was Biomega founded?
Biomega was founded in 2001. It employs 11 to 50 people.
Where is Biomega based?
Biomega is headquartered in Bergen, Norway, in the Europe region.
How does Biomega make money?
One revenue line is on record: B2B Ingredient Sales.
Who are Biomega's main competitors?
Direct peers on record are Scanbio Marine Ingredients, Havsbrún, TripleNine Group, Symrise Diana Pet Food and FF Skagen. Others are VivoMega (GC Rieber VivoMega) and BioMar Group. Broad incumbents are Darling Ingredients, Cargill Animal Nutrition and SARIA Group.
Does Biomega have an API?
No public API is recorded for Biomega.
What industry is Biomega in?
Biomega's product category is Marine Functional Ingredients. Its primary akta.pro industry code is AFANADAJ, Seafood By-Products & Fishmeal/Fish Oil Processing (Rendering, Hydrolysates, Collagen), with a secondary code of EUAAAIAJ, Bio-based Food & Flavor Ingredients (Non-fuel Co-products: sweeteners, organic acids, flavors). Its NAICS code is 3117 and its SIC code is 2092.